Insmed is a biopharmaceutical company that develops and commercialises medicines for people with serious and rare diseases, with a particular focus on lung and respiratory conditions. Its main product is an inhaled antibiotic used to treat a persistent lung infection in certain patients. The company also works on other therapies for inflammatory and rare conditions. Insmed is based in the United States and serves patients and clinicians through specialty treatment channels.
On this site Insmed Inc. appears as a stock on the London Exchange (UK), code 0JAV, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3462 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
14/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-26.2%
From 52-week high-54.6%
MomentumWeak
16/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-12.1%
6-month return-33.6%
12-month, skipping last month-25.7%
Stability (higher is calmer)Weak
17/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)60.1%
Worst drawdown, 1 year (smaller is calmer)-56.1%
LiquidityWeak
37/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.20M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 91.59 – 214.00Daily closes, split-adjusted
Signals
50-day average119.09
200-day average129.67
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)5.40
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 1 neutral · 10 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
100.2
Bearish
EMA 10
101.0
Bearish
SMA 20
108.6
Bearish
EMA 20
106.5
Bearish
SMA 50
119.1
Bearish
EMA 50
112.7
Bearish
SMA 100
111.8
Bearish
EMA 100
117.1
Bearish
SMA 200
129.7
Bearish
EMA 200
123.1
Bearish
Oscillators (daily)
RSI (14)
27.62
Bullish
MACD (12, 26)
-6.42
Bearish
Momentum (12)
-17.35
Bearish
Stochastic %K (14)
6.69
Bullish
Williams %R (14)
-93.31
Bullish
CCI (20)
-102.0
Bullish
Pivot points (classic, last session)
S3
89.16
S2
91.58
S1
93.66
Pivot
96.08
R1
98.16
R2
100.6
R3
102.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
